Susanne Arnold

University of Kentucky

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

george weiner

University of Iowa Healthcare

UNITED STATES

View details

Ryan Gentzler

University of Virginia

UNITED STATES

View details

Marion Dawn Teare

Professor of Biostatistics

Newcastle University

UNITED KINGDOM

View details

Triantafillos Liloglou

Senior Lecturer

Edge Hill University

UNITED KINGDOM

View details

Philip Haycock

Senior Lecturer in Cancer Epidemiology

University of Bristol

UNITED KINGDOM

View details

Geoffrey Liu

Professor

University of Toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Susanne Arnold

Research Interests

Explore related searches

Contact this professor

Articles (10)

Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy

I am hiQ—a novel pair of accuracy indices for imputed genotypes

Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial

Exceptional Survival Among Kentucky Stage IV Non-small Cell Lung Cancer Patients: Appalachian Versus Non-Appalachian Populations

Factors Predicting Participation in the Prospective Genomic Sequencing Study, Total Cancer Care (TCC), in Kentucky

hPG<sub>80</sub> (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors

A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)

Assessing lung cancer absolute risk trajectory based on a polygenic risk model

Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization

Collaborators (6)

george weiner

Ryan Gentzler

Marion Dawn Teare

Triantafillos Liloglou

Philip Haycock

Geoffrey Liu

Make your next move.